Clinical-pathologic conference in general thoracic surgery: Cardiac lymphoma  by Battafarano, Richard et al.
Clinical-
Pathologic
ConferenceClinical-pathologic conference in general thoracic surgery:
Cardiac lymphomaDr Richard Battafaranoa
Dr Richard Leea
Dr G. Alexander Pattersona
Dr Thoralf Sundta
Dr Fernando Gutierrezb
Dr Farrokh Dehdashtic
Dr Jon Ritterd
Dr Ramaswamy Govindane
Dr Jeffrey Bradleyf
Participants
From the Washington University
School of Medicine
Barnes-Jewish Hospital
Saint Louis, Mo
Thoracic Surgery
Dr Richard Battafarano
Dr Richard Lee
Dr G. Alexander Patterson
Dr Thoralf Sundt
Radiology
Dr Fernando Gutierrez
Nuclear Medicine
Dr Farrokh Dehdashti
Surgical Pathology
Dr Jon Ritter
Medical Oncology
Dr Ramaswamy Govindan
Radiation Oncology
Dr Jeffrey Bradley870 The Journal of Thoracic and CardioCase Presentation
Dr Lee: The patient is a 62-year-old man who had a brief episode of substernal
chest pressure while lifting a heavy object at home. The pressure was alleviated with
a few minutes of rest. Because the patient immediately felt better, he decided to wait
to see his primary care physician at an appointment that was previously scheduled.
He had asked for the appointment because of symptoms of dizziness and nose
bleeding that had occurred during the 3 weeks before the episode of chest pressure.
His medical history is significant for prostate cancer, for which he underwent a
prostatectomy in 1995, and new-onset hypertension that is controlled without
medication.
On review of systems, he reported a little bit of increased shortness of breath over
the past 6 months. He was able to walk a mile on flat ground, but after 2 flights of
stairs, he became dyspneic. Also, over the past 6 months, he had a morning cough,
with clear, thin mucous production. He reported long-standing reflux and constipa-
tion, for which he took stool softeners.
Neurologically, he mentioned having 3 episodes of dizziness over 3 weeks, but
he never had syncope. He also had a history of ocular migraines for approximately
2 years.
Social history consisted of working as a serviceman for a heating and air-
conditioning company. He had been exposed to asbestos about 35 years prior. He
has a 50 pack-year smoking history but stopped smoking 12 years before presen-
tation. He drinks an occasional glass of wine.
His family history is only significant for a heart attack that his father had at the
age of 61 years and a mother with dementia. His allergies include tetanus shots made
from horse serum and poison ivy.
The results of his physical examination were unremarkable. He had no palpable
adenopathy. His neck and head were not edematous. His lungs were clear, and his
heart had a regular rate and rhythm. He had no chest wall tenderness. His abdomen
was soft without mass, and his extremities had no cyanosis or clubbing.
After the episode of chest pressure, he was fine for the next several days.
Eventually, he went to his primary care physician about the nosebleeds and dizzi-
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pressure and his family history of heart disease, he was
concerned. Despite a normal electrocardiogram (ECG), the
patient underwent a stress test. The stress test showed an
ejection fraction of 70% and normal function. However,
there was some abnormal uptake of thallium in the base of
the heart in the rest images. This was suggestive of some
kind of malignancy and led to a computed tomographic
(CT) scan. We can now review the radiographic studies.
Dr Gutierrez: The chest radiograph is normal. Now let
us examine the thallium scan (Figure 1). These are the left
anterior oblique views. Here is the left ventricle; you can see
that the uptake is normal. In the area in question, there were
some concerns about an area of uptake on top of the right
ventricle. That led to the CT scan (Figures 2 and 3). Let me
start from the lower mediastinum, and we can work our way
down. The superior mediastinum is normal, but as we get
into the base of the heart, we can see that there is a soft
tissue mass. Here is the right atrial appendage, the aorta, and
the pulmonary arteries. There is a soft tissue mass sitting on
Figure 1. Thallium scan.Figure 2. CT scan.
The Journal of Thoracitop of the atrioventricular groove. As we look lower, we can
see the mass encasing the right coronary artery. Fortunately,
there is contrast, indicating good flow within the vessels.
Therefore, all that tissue around the atrioventricular groove
is infiltrated and extends down about this far. There are just
a few normal-sized lymph nodes. At the time, we thought
that this probably represented some kind a sarcoma, maybe
an angiosarcoma or a fibrosarcoma.
Dr Lee: We planned to biopsy this mass, but it was
obviously not amenable to a percutaneous approach. Before
the biopsy, the patient underwent further cardiac evaluation.
This included echocardiography and cardiac catheterization.
The echocardiogram showed completely normal cardiac and
valve function; however, a large right ventricular mass was
seen. After that, he underwent cardiac catheterization, the
results of which were completely normal. Unfortunately,
after his catheterization, he had transient blindness that
lasted about 48 hours.
Dr Govindan: Does he have an atrial septal defect? Was
this a paradoxical embolus?
Figure 3. CT scan.Figure 4. Biopsy, low power.
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performed, and its results were normal. After he had this
temporary blindness, further workup included normal ca-
rotid duplex imaging, a normal head CT scan, and a mag-
netic resonance angiogram (MRA). The MRA showed no
ischemic insult, no cerebral mass, and normal carotid arter-
ies. Fortunately, he recovered from this event and then
underwent further preoperative evaluation. Finally, a
positron emission tomographic (PET) scan was performed
to rule out any other metastatic site.
Dr Patterson: What was the relationship between the
cardiac catheterization and the blindness?
Dr Lee: Full visual field bilaterally occurring immedi-
ately afterward.
Dr Battafarano: They thought it was a reaction to dye,
especially after they did the MRA of the head. There was
not anything to suggest an embolic phenomenon, and it did
Figure 5. Biopsy, high power.Figure 6. Biopsy, higher power.
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reaction to the dye and the contrast.
Dr Govindan: Do you know whether this has been re-
ported after routine cardiac catheterizations?
Dr Battafarano: This has happened before. It is not
common, but it was not the first time that our cardiologists
have seen this. Our cardiologists tell me that this phenom-
enon occurs once or twice a year at high-volume centers.
Now we can review the PET study?
Dr Dehdashti: The PET study on this patient showed an
area of increased uptake in the anterior mediastinum supe-
rior to the right ventricle. The standardized uptake value
was 2.8, which is in the malignant range. However, this
degree of uptake is not typical for a high-grade malignant
sarcoma. I think a low-grade tumor or even sometimes a
benign lesion might have a similar degree of fluorodeoxy-
glucose uptake. The scan is otherwise unremarkable.
Figure 7. CD20 stain.Figure 8. CD43 stain.
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room. Through a median sternotomy, we searched for but
did not find any abnormal mediastinal nodes. We then
opened the pericardium and found an infiltrating mass on
the right ventricle. We performed 2 incisional biopsies,
controlled the bleeding with some pressure, and closed.
Dr Battafarano: This was very interesting. The process
was not a disease of the para-aortic nodal tissue proper; it
really involved the right ventricle. We actually put a flow
probe on the mass to find the right coronary artery because
we did not want to damage it during any of our biopsies.
The mass was infiltrative and very thickened, as predicted
by the CT scan. However, as it coursed along the right
ventricle, the ventricle became more and more normal. The
apex of the ventricle was completely soft and normal. There
was a single focus. There were no inflammatory adhesions
between the pericardium and the ventricular surface. It was
simply a mass in the ventricle that went right up to the base
of the heart and involved the lower part of the aorta. That is
what we biopsied. It was unclear by means of palpation as
to the depth of involvement.
Dr Ritter: This is the low-power view from one of the
biopsy specimens (Figure 4). You can see the surface ap-
pears to be epicardial. Underneath lies this very dense
lymphoid infiltrate. At higher power, there are several ger-
minal centers within the infiltrate (Figure 5). These have
macrophages within them. They do appear polarized, which
is one of the features that allow us to interpret them as
reactive rather than neoplastic follicles. Extending in be-
tween them was a fairly diffuse infiltrate of small lympho-
cytes. On somewhat higher power, you can see that this is a
polymorphic mixture. We have lymphocytes, plasma cells,
and some eosinophils throughout (Figure 6). You can also
see a lot of these endothelial cells from little reactive vas-
cular spaces. This is very vascular, and the lymphoid com-
ponent itself is very bland. Any of the larger cells that you
see here that look a little atypical are actually associated
with the vessels. They are the reactive endothelial cells and
not the lymphoid component. There were also a series of
immunostains done. This is for CD20, which we use as a
B-cell marker (Figure 7). You can see these germinal cen-
ters here, as well as numerous B cells separating these
follicles. A CD3 stain for T cells showed very few T cells
within the germinal centers, but more of them were present
through the interstitium, for a mixture of B and T cells. A
stain for CD43, another T-cell marker, showed many more
CD43 cells in between follicles than we found with CD3
(Figure 8). This suggests that there is some aberrant expres-
sion of CD43 on these B cells. This aberrant expression is
a feature that we see in some B-cell lymphomas.
We also had fresh tissue available for flow cytometry.
There are some atypical features in this specimen, in-cluding the density, the location, and this aberrant expres-
The Journal of Thoracision of CD43 in the B cells. However, this does not meet the
diagnostic criteria for lymphoma. This tissue is most con-
sistent with a diagnosis of benign lymphoid infiltrate. I
suppose that raises a couple of other possibilities. Taken by
itself, this would be consistent with reactive lymphoid tissue
around some other lesion. However, from everything else
we have seen, it seems like the mass was fairly homoge-
neous. Therefore, I do not think sampling is going to explain
this finding. You can see dense lymphoid infiltrates in
severe myocarditis, but again, that does not really seem to fit
the clinical picture. I think we are basically left with an
atypical lymphoid infiltrate as a diagnosis.
Dr Govindan: Did he travel outside the United States
before this developed? You can see myocardial lymphoid
infiltrates in some parasitic diseases.
Dr Ritter: I think that is true, but there is no evidence
that he has any kind of myocardial disease other than this
localized mass. If you transposed this tissue into a lymph
node, you would say it was just some kind of reactive
lymphoid hyperplasia. If you put it in other sites where you
get these kind of extranodal processes (eg, the skin or
gastrointestinal tract), that would still come under the head-
ing of lymphoid hyperplasia. It does not have monoclonal
expression, and by immunostaining, it shows a mixed pat-
tern. It has reactive germinal centers, and there is no atyp-
ical monotonous lymphoid population that you can identify.
Our concern is that this is a low-grade marginal-zone lym-
phoma. Unfortunately, I do not think it meets the diagnostic
criteria.
With the vascular proliferation and the number of plasma
cells present, Castleman’s disease is another possibility.
You can find Castleman’s disease in unusual locations, and
this process does contain some of its features. However, I do
not think that is what we have here. I would put it in the
broad category of reactive lymphoid hyperplasia. Some-
times the diagnosis is clear if you can identify a primary
site, like on the skin if the patient had an insect bite.
Dr Govindan: Castleman’s disease spans a wide spec-
trum from indolent localized disease to extensive multicen-
tric symptomatic disease.
Dr Ritter: Yes, there are both multicentric and isolated
forms. He had a PET scan and CT scan. He does not have
evidence of adenopathy anywhere else. Even if we said this
was involvement of the heart by a lymphoma, we would
expect that the heart is not the primary site and that ade-
nopathy would be present elsewhere. I understand there is
maybe some question about the inguinal nodes on the PET
scan. I think that if he has any adenopathy elsewhere, we
should biopsy the nodes to make sure that he does not have
a low-grade lymphoma. We just cannot meet the diagnostic
criteria for lymphoma.
Dr Govindan: As you know, human herpesvirus 8
(HHV 8) has been associated with Castleman’s disease. Do
c and Cardiovascular Surgery ● Volume 130, Number 3 873
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am going a step ahead. The picture is not all that classic for
Castleman’s disease.
Dr Ritter: That is a good point. I do not know what
tissue we still have left.
Dr Govindan: I want to make the point that typically
HHV 8–associated Castleman’s disease is often multicen-
tric disease.
Dr Battafarano: There are some gene-rearrangement
studies that are currently pending to rule out lymphoma.
Clearly this might be benign-looking tissue, but it is in the
wrong place. On the basis of its location, we are going to
pursue further characterization.
Dr Ritter: The gene-rearrangement studies are still
pending and ideally should be done within the next few
days. It is unclear whether that alone would be sufficient to
make a diagnosis of lymphoma. Again, it is clear that in
some reactive conditions, you will detect a clonal rearrange-
ment by using molecular diagnostics.
Dr Govindan: This presentation seems highly unusual
for lymphoma.
Dr Battafarano: I think the next step is to obtain another
CT scan approximately 6 weeks after surgical intervention and
form a new baseline with some of the postoperative changes.
Obviously, if this grows or if something else arises in the
mediastinum, then we would lean toward treating it or dealing
with it in another fashion. If it just stays like this and does not
change at all, then we might be willing to follow it. I think the
only way to approach future therapy is with a baseline CT scan
in about 6 weeks and subsequent serial examinations.
Dr Lee: What about serial PET scans? Would that play
a role?
Dr Battafarano: If it is in that low-grade range, I do not
think it would help.
Dr Bradley: Is this transmural?
Dr Battafarano: The technologist did not see any heartmuscle. We do not really know.
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obviously infiltrates the epicardial fat, but we do not know
how deep it goes.
Dr Bradley: It is just not behaving like something be-
nign. It could be infiltrating heart muscle, right? If it turns
out to be a lymphoma and you treat it, what is going to
happen? Is it possible that the ventricle could rupture as a
result of treatment for lymphoma?
Dr Patterson: He had an echocardiogram, a catheteriza-
tion, and a stress test. He had several very good functional
studies that tell you that his heart is not involved.
Dr Battafarano: Radiographically, his right coronary
artery was smooth and open, and therefore this encases it
externally. One of the reasons that we did the catheterization
was to be sure that there was not either extrinsic compres-
sion or even transmural involvement through the arterial
wall.
Dr Lee: Postoperatively, he went home on day 3. He
was subsequently readmitted for generalized weakness and
fatigue, received intravenous hydration, and was discharged
again.
Dr Govindan: Did he have a bone marrow biopsy?
Dr Battafarano: Not yet. I think Dr Bartlett plans on
doing one.
Dr Patterson: So this was all within the pericardium?
Dr Battafarano: Correct. It did not involve the pericar-
dium at all. In other words, I was thinking that if this was
response to some myocarditis or pericarditis, you would
expect the pericardium to have adhesions, but there was a
free pericardial space with clear fluid, and it just had some
reactive cells in it. It did not look like it was myocarditis or
a pericarditis.
Dr Govindan: It possibly could be a picture consistent
with sarcoid.
Dr Lee: Follow-up gene-rearrangement studies con-
firmed that this was, in fact, a low-grade lymphoma.
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